Gal Cohen serves as the CEO / President of MediWound Ltd..
Sharon Malka CPA, MBA
Chief Financial & Operation Officer
Mr. Sharon Malka, C.P.A., MBA, has been the Chief Financial & Operation Officer at MediWound Ltd. since April 2007. Mr. Malka served as a Partner at Varinace Economic Consulting Ltd., a full-service consulting firm and as a Senior Manager at Kesselman Corporate Finance, a division of PricewaterhouseCoopers Global Network (PwC). Mr. Malka's experience includes business and economic consulting for a number of public companies regarding valuations, SEC filing, feasibility studies and financial/strategic planning. Mr. Malka holds a B.Sc. in Business Administration from the Business Management College, Israel and an MBA from Bar Ilan University, Israel.
Carsten Henke B.Sc.
Chief Commercial Officer of Europe
Mr. Carsten Henke, B.Sc. has been Chief Commercial Officer of Europe at MediWound Ltd. since May 2014 served as the Managing Director of Mediwound Germany Gmbh since July 2013. Mr. Henke is responsible for European commercialization since July 2013. Prior to joining MediWound, he held several senior management positions at Teva Pharmaceutical Industries Ltd. as General Manager in Spain and as Director of Marketing and Sales in Germany. During this period, he established various sales and marketing organizations and has successfully launched and marketed pharmaceutical products. Amongst them, Copaxone ?? , Teva??? s flagship innovative product, which became the number one prescribed MS treatment in Germany under his leadership. In his long career, he has worked in many additional commercial roles in Serono, Sanofi and the Merck Group. Mr. Henke holds a cum laude B.Sc. in European Management from the ESB Business School at Reutlingen University and a ??? Graduado Superior??? in International Business Administration- E-4 from Comillas Pontifical University ICAI ??? ??? ICADE in Madrid.
Lior Rosenberg M.D.
Co-Founder & Chief Medical Technology Officer
Prof. Lior Rosenberg, M.D Co-founded MediWound Ltd. and has also been its Chief Medical Officer since 2001. Prof. Rosenberg's years of pioneering work with the product and his expertise and extensive personal ties with key opinion leaders in the field of burns and wound care form the clinical basis of MediWound's development program. He served as a Director of MediWound Ltd. from 2001 to June 12, 2014. He serves as the Head of the Department of Plastic Surgery at Soroka University Medical Center in Beer Sheva, heads the unit for Cleft Lip Palate & Craniofacial deformities at Meir Medical Center, Kfar Saba. He serves as a Professor of Medicine at the Ben-Gurion University Medical School in Beer Sheva. He has given more than 60 presentations relating to Debrase??? at international conferences and published numerous peer reviewed papers, 2 of the papers were specifically about Debrase???.
Lassen Sie MediWound Ltd. wissen, dass Sie dort arbeiten möchten
Sagen Sie MediWound Ltd., dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt MediWound Ltd. die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Gleichberechtigungs BewertungWie positiv bewerten Frauen ihre Gesamterfahrung mit MediWound Ltd.
N/A
Herkunftsvielfalts BewertungWie positiv bewerten Minderheiten ihre Gesamterfahrung mit MediWound Ltd.